Breaking News: Vertex makes $4.9B acquisition, the largest in its history

Vertex Pharmaceuticals Inc. has agreed to buy a Seattle-based biotech developing a drug to treat kidney disease for $4.9 billion, the biggest acquisition in the Boston company’s history. Vertex Pharmaceuticals Inc. has agreed to buy a Seattle-based biotech developing a drug to treat kidney disease for $4.9 billion, the biggest acquisition in the Boston company’s history. [Boston Business Journal]( April 10, 2024 Breaking News [Vertex makes $4.9B acquisition, the largest in its history]( Vertex Pharmaceuticals Inc. has agreed to buy a Seattle-based biotech developing a drug to treat kidney disease for $4.9 billion, the biggest acquisition in the Boston company’s history. [Read Full Article]( Related News [Vertex CEO's compensation crosses $20M threshold]( [Local biotech sets highest drug price tag in history]( [Bluebird secures up to $175M in debt financing deal]( [Local biotech aims to use AI to predict measles outbreaks]( [View as a Web Page]( [Unsubscribe]( | [Manage Preferences]( All rights reserved. © Boston Business Journal Email sent by Boston Business Journal 70 Franklin Street, 8th Floor Boston, MA 02110 USA